PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34924132-10	2022	Nafamostat has a protective effect against HBMVEC after exposure to thrombin and hypoxia, suggesting its role in improving the neurological outcomes after SAH.	nafamostat	0-10	coagulation factor II	Mus musculus	68-76	
34924132-8	2022	Nafamostat exerted no significant effect on the SAH grade or cerebral blood flow; however, it improved the neurological behavior and suppressed the thrombin and MMP-9 expression.	nafamostat	0-10	coagulation factor II	Mus musculus	148-156